Intuitive Surgical (ISRG) Tops Q1 EPS by 9c

Go back to Intuitive Surgical (ISRG) Tops Q1 EPS by 9c

Leerink Partners Raises Price Target on Intuitive Surgical (ISRG) to $710 Following Strong 1Q

April 20, 2016 10:15 AM EDT

Leerink Partners reiterated an Outperform rating on Intuitive Surgical (NASDAQ: ISRG), and raised the price target to $710.00 (from $700.00), following the company's 1Q earnings report. ISRG reported revenue results of $595M, slightly ahead of consensus' $591M. EPS also beat consensus with $4.42, compared to $4.33.

Analyst Richard Newitter... More

Intuitive Surgical (ISRG) Procedure Growth Drives Guidance Increase - Wedbush

April 20, 2016 8:59 AM EDT

Wedbush analyst, Tao Levy, noted that Intuitive Surgical's (NASDAQ: ISRG) robots were very busy this quarter. Procedure growth exceeded expectations at 17% yr/yr vs consensus of 12%, and management raises the guidance range to 12%-14% from 9%-12%.

Looking forward, the adoption in general surgery, specifically hernia repair and colorectal surgery, has hit an inflection point that... More

Intuitive Surgical (ISRG) PT Raised to $700 at Evercore ISI

April 20, 2016 7:40 AM EDT

Evercore ISI analyst Vijay Kumar raised his price target on Buy-rated Intuitive Surgical (NASDAQ: ISRG) to $700.00 (from $675.00) following Q1 results.

The firm lowered FY16 EPS from $21.30 to $20.75 mainly due to lower systems revenues (impact of upgrades + leases) offset partly by higher procedure growth assumptions. FY17 EPS was raised from $24.00 to... More

Intuitive Surgical (ISRG) PT Raised to $610 at Piper Jaffray

April 20, 2016 6:35 AM EDT

Piper Jaffray analyst Matt O'Brien raised his price target on Intuitive Surgical (NASDAQ: ISRG) to $610.00 (from $550.00) following solid Q1 results but maintained a Neutral rating.

O'Brien commented, "This evening, Intuitive announced solid Q1 results driven by stronger than expected procedure growth (general... More